Results 111 to 120 of about 25,969 (231)

HELLP syndrome.

open access: yes, 2015
OBJETIVO: Describir las características clínicas y las complicaciones materno perinatales del síndrome HELLP. DISEÑO: Estudio retrospectivo descriptivo. MATERIAL Y MÉTODO: Casos de síndrome HELLP atendidos en el Hospital Nacional Guillermo Almenara lrigoyen (HNGAI) en 1999. RESULTADOS: la incidencia de síndrome HELLP fue 16.3 por 1000 nacidos vivos, 16
Arana, Cecilia, Donayre, Abelardo
openaire   +2 more sources

Ethnic, geographical and altitude considerations and maternal mortality associated with HELLP syndrome in Ecuador: a population-based cohort study

open access: yesBMC Pregnancy and Childbirth
Background Eclampsia and pre-eclampsia rank as the third leading causes of maternal death in Ecuador, following pre-existing chronic diseases and postpartum haemorrhage, as reported by the Ecuadorian National Institute of Statistics and Census (INEC). In
Marco Coral-Almeida   +5 more
doaj   +1 more source

Primary Antiphospholipid Syndrome: Pregnancy Outcome in a Portuguese Population [PDF]

open access: yes, 2009
Introduction:Women with antiphospholipid syndrome(APS) may suffer from recurrent miscarriage, fetal death, fetal growth restriction (FGR), pre-eclampsia, placental abruption, premature delivery and thrombosis.
Borges, A   +3 more
core  

Az ösztrogén receptor gén polimorfizmus és a lipoproteinek, valamint egyes alvadási tényezők kapcsolata. Az ösztrogén receptor gén polimorfizmus szerepe a cardiovascularis betegségek rizikójában = Association of estrogen receptor gene polymorphisms with serum lipoprotein levels and hemostatic factors. The role of estrogen receptor gene polymorphisms in the risk of cardiovascular diseases [PDF]

open access: yes, 2007
Az ösztrogének az ösztrogén receptor ?-n keresztül számos (részben lokális, részben szisztémás) hatást gyakorolnak a cardiovascularis rendszerre. Kutatási projektünk keretében azt vizsgáltuk, hogy az ösztrogén receptor ?
Karádi, István, Molvarec, Attila
core  

Treatment of the pregnancy hypertensive disorders [PDF]

open access: yes, 2011
Liječenje hipertenzivne bolesti u trudnoći uključuje antihipertenzivnu terapiju, antikonvulzivnu profilaksu, kontroliranu ekspanziju volumena (onkotsku terapiju), liječenje poremećaja koagulacije, te dovršenje trudnoće. Ciljevi antihipertenzivne terapije
Dubravko Habek   +2 more
core  

Construction of the risk prediction model for gestational hypertension patients with HELLP syndrome

open access: yesHuli yanjiu
ObjectiveTo analyze the influencing factors of HELLP syndrome in patients with gestational hypertension,and to construct the risk prediction model of gestational hypertension patients with HELLP syndrome.MethodsA total of 470 patients with gestational ...
CHEN Chunrong   +5 more
doaj  

Gambaran Luaran Hasil Persalinan pada Pasien Preeklamsia-eklamsia di RSUD Dr Soedarso Periode 1 Januari 2011-31 Desember 2011 [PDF]

open access: yes, 2014
Background. Preeclamsia is a pregnancy-specific syndrome whichreduce organ perfusion because of vasospasm and endothelial activation.The combination of proteinuria and hypertension during pregnancy willincrease the risk of perinatal and maternal ...
Sinaga, R. P. (Riris)
core  

Immunohistochemical and bioinformatics analysis of the placental BCL-2 and Beclin-1 expressions in preeclampsia and HELLP syndrome

open access: yesJournal of Obstetrics and Gynaecology
Background This study aimed to examine the alterations in apoptosis and autophagy in placental tissues from normal pregnancies compared to those affected by preeclampsia (PE) and HELLP (haemolysis, elevated liver enzymes, low platelets) syndrome.
Süleyman Cemil Oğlak   +7 more
doaj   +1 more source

Preeclampsia & eclampsia [PDF]

open access: yes, 2009
This issue of eMedRef provides information to clinicians on the pathophysiology, diagnosis, and therapeutics of preeclampsia and ...
Chae, Sung Y.
core  

HELLP-Syndrom [PDF]

open access: yesGynäkologisch-geburtshilfliche Rundschau, 1993
F. Abroug   +7 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy